Valence ロゴ
人気
ログイン
Loading data for NXTC — first visit, this takes a few seconds.

ウォッチリストに追加

NextCure Inc.

NasdaqGS: NXTC · リアルタイム株価 · USD
6.96
+0.31 (4.66%)
終値時点： Aug 19, 2026, 2:12 PM

NextCure Inc. (NXTC) Stock Price, Analysis & Data

4.66%

データがありません

買気配4.98
時価総額31.84M
売上高（TTM）n/a
純利益（TTM）-42.75M
ベータ1.27
EPS（TTM）-8.28
PER（TTM）n/a
予想PER-1.21
PBR（TTM）0.70
PSR（TTM）n/a
Earnings Daten/a
売気配8.96
出来高36,969
平均出来高（20日）2,199,008
始値6.72
前日終値6.65
当日レンジ6.72 - 7.26
52週レンジ1.55 - 15.74
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

NXTCについて

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targetin...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 May 9, 2019
従業員数 40
上場取引所 NasdaqGS
ティッカー NXTC
ウェブサイト https://www.nextcure.com
企業情報の全文

業績

2025年のNextCureの売上高は0で、前年の0からundefined%の増加でした。 利益は-55.84Mで、0.34%の増加でした。

財務諸表

決算サプライズ

NextCureはAug 6, 2026に四半期決算を発表しました：
  • 売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
  • EPSは -1.85 で、予想を上回りました 0.07, うち 83.61% の前年比増加にあたります.
    news image

    1か月前 · MT Newswires

    Sector Update: Healthcare Stocks Fall Late Afternoon

    Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the

    news image

    1か月前 · BioPharma Dive

    Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill

    Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.

    news image

    9か月前 · Zacks

    Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

    The average of price targets set by Wall Street analysts indicates a potential upside of 107.9% in NextCure (NXTC). While the effectiveness of this highly sought-after metric is questionable, the posi...

    news image

    10か月前 · Simply Wall St.

    Companies Like NextCure (NASDAQ:NXTC) Could Be Quite Risky

    We can readily understand why investors are attracted to unprofitable companies. For example, although...